Default: Diabetes and Metabolic Syndrome: Clinical Research and Reviews

ISSN: 1871-4021

Journal Home

Journal Guideline

Diabetes and Metabolic Syndrome: Clinical Research and Reviews Q1 Unclaimed

Elsevier B.V. Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Diabetes and Metabolic Syndrome: Clinical Research and Reviews is a journal indexed in SJR in Medicine (miscellaneous) and Endocrinology, Diabetes and Metabolism with an H index of 83. It has an SJR impact factor of 1,313 and it has a best quartile of Q1. It has an SJR impact factor of 1,313.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

1,313

SJR Impact factor

83

H Index

145

Total Docs (Last Year)

987

Total Docs (3 years)

6390

Total Refs

5953

Total Cites (3 years)

866

Citable Docs (3 years)

3.99

Cites/Doc (2 years)

44.07

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

WITHDRAWN: Effects on lipid profile of supplementation with vitamin D in type 2 diabetic patients with vitamin D deficiency

View more

Influence of maternal diabetes on serum leptinemic and insulinemic status of the offspring: A case study of selected patients in a tertiary care hospital in Bangladesh

View more

Use of HbA1c to diagnose type 2 diabetes mellitus among high risk Sri Lankan adults

View more

Short-term predictors of amputation in patients with diabetic foot ulcers

View more

Knowledge, attitude and practice of exercise for plasma blood glucose control among patients with type-2 diabetes

View more

Is vitamin D status a predictor glycaemic regulation and cardiac complication in type 2 diabetes mellitus patients?

View more

Knowledge, attitude and practice of Sudanese pharmacist with regard to management of diabetes during Ramadan: A cross-sectional survey

View more

Inflammatory markers and control of type 2 diabetes mellitus

View more

Influenza and diabetes mellitus

View more

Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes

View more

Glycemic and non-glycemic targets in younger and older North Indian subjects with type 2 diabetes in a Tertiary care hospital: A 10 year's retrospective data analysis

View more

Diabetes and vascular disease: From pathogenesis to treatment

View more
SHOW MORE ARTICLES

A comparative study of the clinical profile of fibrocalculous pancreatic diabetes and type 2 diabetes mellitus

View more

Components of metabolic syndrome and the incidence of type 2 diabetes in an elderly Taiwanese cohort

View more

WITHDRAWN: Smoking cessation and the incidence of pre-diabetes and type 2 diabetes: A cohort study

View more

WITHDRAWN: The increase of dairy intake is the main dietary factor associated with reduction of body weight in overweight adults after lifestyle change program

View more

THE metabolic syndrome and accurate cardiovascular risk prediction in persons with type 2 diabetes mellitus

View more

Monocyte chemoattractant protein-1 -2518 polymorphism is not associated with diabetic retinopathy in Japanese type 2 diabetes

View more

Reduced serum resistin levels in diabetic patients: Study from western India

View more

Components of the metabolic syndrome (MTS), hyperinsulinemia, and insulin resistance in obese Israeli children and adolescents

View more

The metabolic syndrome and related diseases: Need for a new journal, innovative research and fresh viewpoints

View more

The metabolic syndrome in type 2 diabetic patients in Gorgan: According to NCEP ATPIII and IDF definitions

View more

Duration of diabetes and prevalence of diabetic retinopathy: Istanbul Diabetic Retinopathy Study - IDRS results 1

View more

Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes: Sub-analysis of a Phase IV open-label trial in Chinese patients

View more

FAQS